-$4.4M
Net insider buying / selling at NovoCure (NVCR) over the last 2 years. Updated Jun 5, 2026

Are NovoCure Insiders Buying or Selling?

NovoCure (NVCR) has had no reported insider transactions in the past 90 days. The most recent was Frank Leonard, who sold 34,273 shares at $17.93 on June 4, 2026.

Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the NVCR AI Score. For government officials trading this stock, see NVCR congressional trading.

Who’s Trading NovoCure Stock?

InsiderActivityTradesLast Trade
Frank Leonard Sold $2.1M 15 Jun 4, 2026
Ashley Cordova Bought $1,000,000 8 Sep 5, 2025
WILLIAM DOYLE Sold $930,000 2 Mar 3, 2026
Mukund Paravasthu Sold $850,000 15 Mar 5, 2026
Uri Weinberg Sold $410,000 8 Mar 4, 2026
Christoph Brackmann Bought $170,000 3 Mar 4, 2026

Recent NovoCure Insider Transactions

Insider Transaction Date Type Shares Price Value
Frank LeonardJun 4, 2026Sell34,273$17.93$610,000
Kristin StaffordJun 2, 2026Sell2,945$15.77$46,000
Allyson OceanJun 2, 2026Sell2,945$15.77$46,000
Timothy ScannellJun 2, 2026Sell2,945$15.77$46,000
VERNON W ANTHONYJun 2, 2026Sell2,945$15.77$46,000
David HungJun 2, 2026Sell2,945$15.77$46,000
GABRIEL LEUNGJun 2, 2026Sell2,945$15.77$46,000
JERYL HILLEMANJun 2, 2026Sell2,945$15.77$46,000
Mukund ParavasthuMar 5, 2026Sell43,246$13.77$600,000
Christoph BrackmannMar 4, 2026Sell6,412$13.31$85,000
Mukund ParavasthuMar 4, 2026Sell5,377$13.31$72,000
Nicolas LeupinMar 4, 2026Sell1,100$13.31$15,000
Puri Michal NathMar 4, 2026Sell1,100$13.31$15,000
Frank LeonardMar 4, 2026Sell5,607$13.31$75,000
Uri WeinbergMar 4, 2026Sell6,412$13.31$85,000
WILLIAM DOYLEMar 3, 2026Sell50,557$12.79$650,000
WILLIAM DOYLEMar 3, 2026Sell21,330$13.43$290,000
Frank LeonardMar 2, 2026Sell7,232$13.49$98,000
Uri WeinbergMar 2, 2026Sell3,272$13.33$44,000
Mukund ParavasthuMar 2, 2026Sell408$13.49$5,500
Mukund ParavasthuFeb 27, 2026Sell1,555$13.66$21,000
Nicolas LeupinFeb 27, 2026Sell1,029$13.66$14,000
Puri Michal NathFeb 27, 2026Sell1,441$13.66$20,000
Frank LeonardFeb 27, 2026Sell9,734$13.66$130,000
Uri WeinbergFeb 27, 2026Sell7,461$13.84$100,000
Ashley CordovaSep 5, 2025Buy81,550$12.22$1,000,000
Christoph BrackmannJul 29, 2025Buy10,000$11.63$120,000
Christoph BrackmannJul 29, 2025Buy5,000$11.5$58,000
Kristin StaffordJun 3, 2025Sell999$17.28$17,000
GABRIEL LEUNGJun 3, 2025Sell999$17.31$17,000
Martin MaddenJun 3, 2025Sell999$17.19$17,000
Timothy ScannellJun 3, 2025Sell999$17.32$17,000
JERYL HILLEMANJun 3, 2025Sell999$17.26$17,000
Allyson OceanJun 3, 2025Sell999$17.29$17,000
VERNON W ANTHONYJun 3, 2025Sell999$17.35$17,000
David HungJun 3, 2025Sell999$17.3$17,000
Frank LeonardJun 2, 2025Sell21,717$17.22$370,000
Frank LeonardJun 2, 2025Sell6,600$17.99$120,000
Frank LeonardJun 2, 2025Sell1,879$19.01$36,000
Mukund ParavasthuMay 3, 2025Sell592$17.91$11,000
Frank LeonardMar 3, 2025Sell2,527$18.54$47,000
Ashley CordovaMar 3, 2025Sell2,053$18.54$38,000
Uri WeinbergMar 3, 2025Sell268$18.92$5,100
Mukund ParavasthuMar 3, 2025Sell250$18.54$4,600
Uri WeinbergFeb 28, 2025Sell4,326$18.78$81,000
Ashley CordovaFeb 28, 2025Sell2,341$18.28$43,000
Frank LeonardFeb 28, 2025Sell2,770$18.28$51,000
Uri WeinbergFeb 28, 2025Sell4,326$18.78$81,000
Frank LeonardFeb 28, 2025Sell2,770$18.28$51,000
Ashley CordovaFeb 28, 2025Sell2,341$18.28$43,000
Uri WeinbergFeb 28, 2025Sell311$18.31$5,700
Mukund ParavasthuFeb 28, 2025Sell368$18.28$6,700
Uri WeinbergFeb 28, 2025Sell311$18.31$5,700
Mukund ParavasthuFeb 28, 2025Sell368$18.28$6,700
Frank LeonardFeb 27, 2025Sell10,277$19.92$200,000
Frank LeonardFeb 27, 2025Sell10,277$19.92$200,000
Ashley CordovaFeb 27, 2025Sell9,345$19.92$190,000
Ashley CordovaFeb 27, 2025Sell1,808$20.55$37,000
Frank LeonardFeb 27, 2025Sell1,989$20.55$41,000
Puri Michal NathFeb 27, 2025Sell1,162$19.92$23,000
Mukund ParavasthuFeb 27, 2025Sell1,379$19.92$27,000
Puri Michal NathFeb 27, 2025Sell1,162$19.92$23,000
Frank LeonardFeb 27, 2025Sell1,989$20.55$41,000
Ashley CordovaFeb 27, 2025Sell9,345$19.92$190,000
Ashley CordovaFeb 27, 2025Sell1,808$20.55$37,000
Mukund ParavasthuFeb 27, 2025Sell1,379$19.92$27,000
Puri Michal NathFeb 27, 2025Sell225$20.55$4,600
Nicolas LeupinFeb 27, 2025Sell830$19.92$17,000
Nicolas LeupinFeb 27, 2025Sell161$20.55$3,300
Mukund ParavasthuFeb 27, 2025Sell267$20.55$5,500
Nicolas LeupinFeb 27, 2025Sell830$19.92$17,000
Nicolas LeupinFeb 27, 2025Sell161$20.55$3,300
Puri Michal NathFeb 27, 2025Sell225$20.55$4,600
Mukund ParavasthuFeb 27, 2025Sell267$20.55$5,500
Mukund ParavasthuJan 11, 2025Sell2,160$26.81$58,000
Mukund ParavasthuNov 2, 2024Sell44$16.69$730
Frank LeonardNov 1, 2024Sell598$15.94$9,500
Mukund ParavasthuNov 1, 2024Sell160$15.88$2,500
Puri Michal NathOct 31, 2024Sell810$15.79$13,000

Frequently Asked Questions: NovoCure Insider Trading

NovoCure insiders have not reported any transactions in the past 90 days.

The most recent sale was by Frank Leonard who sold 34,273 shares on June 4, 2026. View all transactions in the table on this page.

Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.

Cordova Ashley has bought the most NVCR stock in the last 2 years, with a total value of $1,000,000.

Leonard Frank X has sold the most NVCR stock in the last 2 years, with a total value of $2.1M.

The total value of insider transactions for NovoCure in the last 2 years is negative, amounting to -$4.4M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.